Modal close

Hi there,

You trust Democracy Now! to bring you the news stories and global headlines you won't find anywhere else. But did you know that Democracy Now! never accepts money from advertisers, corporate underwriters or governments? This allows us to maintain the editorial independence you rely on—but it also means we need your help. If everyone seeing this gave just $4 a month, it would more than cover our expenses for the entire year—and today a donor will DOUBLE your first month. Please do your part. It takes just a couple of minutes to make sure that Democracy Now! is there for you and everybody else. Thank you so much!
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

The Guardian: Giuliani Helped OxyContin Maker Continue Drug Sales

HeadlineMay 23, 2018

The Guardian is reporting that former New York City Mayor Rudy Giuliani, who is now one of President Trump’s lawyers, helped OxyContin maker Purdue Pharma protect its profits and avoid prison time for its executives back in the mid-2000s. Giuliani represented Purdue Pharma in an investigation into the company’s deceptive marketing practices launched by the U.S. attorney for the Western District of Virginia. Giuliani helped Purdue win a deal that limited future prosecution of the company, avoided prison time for its executives and permitted Purdue to continue doing business with the federal government, allowing Purdue to continue raking in billion-dollar profits. OxyContin is at the center of a national opioid epidemic that has killed an estimated 300,000 people since the late 1990s.

Topics:
The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Up arrowTop